Search research articles
Contact Us
Filters
Showing results (11-20 of 37) with videos related to
Page
of 4
Sort By:
Current Treatment Options in Oncology
|
May 26, 2017
PARP Inhibitors in Prostate Cancer
Praveen Ramakrishnan Geethakumari, Matthew J Schiewer, Karen E Knudsen, et al.
The Journal of Urology
|
June 7, 2006
Clinical outcomes by age in men with hormone refractory prostate cancer: a pooled analysis of 8 Cancer and Leukemia Group B (CALGB) studies
Susan Halabi, Nicholas J Vogelzang, San-San Ou, et al.
Novartis Foundation Symposium
|
June 3, 2004
Histone deacetylase inhibitors: development as cancer therapy
Paul A Marks, Victoria M Richon, Wm Kevin Kelly, et al.
Journal of Geriatric Oncology
|
May 4, 2024
The rates of septicemia in older adults with prostate cancer treated with abiraterone or enzalutamide: A population-based study
Nikita Nikita, Krupa Gandhi, Scott W Keith, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
|
January 15, 2010
Prostate cancer, comorbidity, and participation in randomized controlled trials of therapy
Herta H Chao, Tina Mayer, John Concato, et al.
Cancer Biology & Therapy
|
May 27, 2024
T-Cell redirecting bispecific antibodies: a review of a novel class of immuno-oncology for advanced prostate cancer
Julia Palecki, Amman Bhasin, Andrew Bernstein, et al.
Urologic Oncology
|
June 21, 2021
New and topics: enfortumab vedotin mechanisms of response and resistance in urothelial cancer - What do we understand so far?
Jean Hoffman-Censits, Kara Lombardo, David McConkey, et al.
Cancers
|
September 13, 2025
The Safety of Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer: An Individual-Participant Data Meta-Analysis Based on 14 Randomized Clinical Trials
Amy L Shaver, Nikita Nikita, Swapnil Sharma, et al.
The Canadian Journal of Urology
|
October 25, 2011
Screening for prostate cancer: the current evidence and guidelines controversy
Leonard G Gomella, Xiaolong S Liu, Edouard J Trabulsi, et al.
Contemporary Clinical Trials
|
December 25, 2022
Predictors of consenting to participate in a clinical trial among urban cancer patients
Russell K McIntire, Scott W Keith, Thomas Nowlan, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 37) with videos related to
Sort By:
Page
of 4
Current Treatment Options in Oncology
|
May 26, 2017
PARP Inhibitors in Prostate Cancer
Praveen Ramakrishnan Geethakumari, Matthew J Schiewer, Karen E Knudsen, et al.
The Journal of Urology
|
June 7, 2006
Clinical outcomes by age in men with hormone refractory prostate cancer: a pooled analysis of 8 Cancer and Leukemia Group B (CALGB) studies
Susan Halabi, Nicholas J Vogelzang, San-San Ou, et al.
Novartis Foundation Symposium
|
June 3, 2004
Histone deacetylase inhibitors: development as cancer therapy
Paul A Marks, Victoria M Richon, Wm Kevin Kelly, et al.
Journal of Geriatric Oncology
|
May 4, 2024
The rates of septicemia in older adults with prostate cancer treated with abiraterone or enzalutamide: A population-based study
Nikita Nikita, Krupa Gandhi, Scott W Keith, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
|
January 15, 2010
Prostate cancer, comorbidity, and participation in randomized controlled trials of therapy
Herta H Chao, Tina Mayer, John Concato, et al.
Cancer Biology & Therapy
|
May 27, 2024
T-Cell redirecting bispecific antibodies: a review of a novel class of immuno-oncology for advanced prostate cancer
Julia Palecki, Amman Bhasin, Andrew Bernstein, et al.
Urologic Oncology
|
June 21, 2021
New and topics: enfortumab vedotin mechanisms of response and resistance in urothelial cancer - What do we understand so far?
Jean Hoffman-Censits, Kara Lombardo, David McConkey, et al.
Cancers
|
September 13, 2025
The Safety of Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer: An Individual-Participant Data Meta-Analysis Based on 14 Randomized Clinical Trials
Amy L Shaver, Nikita Nikita, Swapnil Sharma, et al.
The Canadian Journal of Urology
|
October 25, 2011
Screening for prostate cancer: the current evidence and guidelines controversy
Leonard G Gomella, Xiaolong S Liu, Edouard J Trabulsi, et al.
Contemporary Clinical Trials
|
December 25, 2022
Predictors of consenting to participate in a clinical trial among urban cancer patients
Russell K McIntire, Scott W Keith, Thomas Nowlan, et al.
Page
of 4